RecruitingNot ApplicableNCT06244953

Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care


Sponsor

National Cancer Centre, Singapore

Enrollment

240 participants

Start Date

Aug 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.


Eligibility

Min Age: 21 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a palliative care program delivered via phone or video — focused on comfort, quality of life, and supporting both patients and their caregivers — helps people living with advanced heart failure feel better compared to usual care. **You may be eligible if...** - You are 21 years of age or older - You have advanced heart failure (stage C or D) with significant symptoms affecting daily life (NYHA class 2 or higher) - You have been hospitalized for a heart failure-related reason in the past 6 months - You are able to communicate in English or Chinese - You have a phone that allows you to make video or voice calls - Your doctor believes you have at least 6 months of expected survival - Caregivers of eligible patients may also participate if they provide unpaid hands-on care **You may NOT be eligible if...** - You are receiving hospice or end-of-life care only - You are already receiving a structured palliative care program - You cannot communicate in English or Chinese - You do not have a phone or cannot use telecommunication Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTIER-HF-PC

The patient will be assigned to one of the three levels of care which is determined by the results given by Distress Thermometer (DT) and the Integrated Palliative Care Outcome Scale (IPOS).

OTHERUsual Care

Patient continues on clinical care by his/her cardiologist. If the cardiologist picks up their symptoms or other concerns, he/or can be referred to a specialist palliative care physician by the cardiologist.


Locations(4)

National Heart Centre Singapore

Singapore, Singapore

Sengkang General Hospital

Singapore, Singapore

Khoo Teck Puat Hospital

Singapore, Singapore

National Cancer Centre, Singapore

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06244953


Related Trials